Flow cytometric assessment of circulating microparticles - towards a more objective analysis

Romanian Biotechnological Letters

Volumn 16, Issue 3, 2011, Pages 6271-6277

  Huica R ^a,b   Huica S ^a,b   Moldoveanu, E ^a,c  

^a NATIONAL INSTITUTE FOR RESEARCH AND DEVELOPMENT IN MICROTECHNOLOGIES   (Romania)

^b Medas Clinic   (Romania)

^c TITU MAIORESCU UNIVERSITY   (Romania)

Author keywords

Flow cytometry; Microparticles; Overton subtraction; Probability binning; Semi automatic processing

Indexed keywords

EID: 79961034394     PISSN: 12245984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. P. WOLF. The Nature and Significance of Platelet Products in Human Plasma. British Journal of Haematology 13, no. 3 (5): 269-288 (1967).
2. O. MOREL, F. TOTI, B. HUGEL, B. BAKOUBOULA, L. CAMOIN-JAU, F. DIGNAT-GEORGE, & J. FREYSSINET. Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation? Arterioscler Thromb Vasc Biol 26, no. 12 (December 1): 2594-2604 (2006).
3. H. C. ANDERSON, D. MULHALL, & R. GARIMELLA. Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis. Laboratory Investigation; a Journal of Technical Methods and Pathology 90, no. 11: 1549-1557 (2010).
4. D. HELLEY, E. BANU, A. BOUZIANE, A. BANU, F. SCOTTE, A. FISCHER, & S. OUDARD. Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based Chemotherapy. European Urology 56, no. 3: 479-485 (2009).
5. G. CHIRONI, A. SIMON, B. HUGEL, M. DEL PINO, J. GARIEPY, J. FREYSSINET, & A. TEDGUI. Circulating Leukocyte-Derived Microparticles Predict Subclinical Atherosclerosis Burden in Asymptomatic Subjects. Arterioscler Thromb Vasc Biol 26, no. 12: 2775-2780 (2006).
6. F. LANGER, F. K. CHUN, A. AMIRKHOSRAVI, M. FRIEDRICH, S. LEUENROTH, B. EIFRIG, C. BOKEMEYER, & J. L. FRANCIS. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers. Thrombosis and Haemostasis 97, no. 3: 464-470 (2007).
7. N. S. KEY. Platelet tissue factor: how did it get there and is it important? Seminars in Hematology 45, no. 2: S16-20 (2008).
8. R. A. PRESTON, W. JY, J. J. JIMENEZ, L. M. MAURO, L. L. HORSTMAN, M. VALLE, G. AIME, & Y. S. AHN. Effects of Severe Hypertension on Endothelial and Platelet Microparticles. Hypertension 41, no. 2: 211-217 (2003).
9. A. S. LEROYER, P. RAUTOU, J. SILVESTRE, Y. CASTIER, G. LESECHE, C. DEVUE, M. DURIEZ, & al. CD40 Ligand+ Microparticles From Human Atherosclerotic Plaques Stimulate Endothelial Proliferation and Angiogenesis: A Potential Mechanism for Intraplaque Neovascularization. J Am Coll Cardiol 52, no. 16: 1302-1311 (2008).
10. J. SELLAM, V. PROULLE, A. JUNGEL, M. ITTAH, C. MICELI RICHARD, J. GOTTENBERG, F. TOTI, & al. Increased levels of circulating microparticles in primary Sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Research & Therapy 11, no. 5: R156 (2009).
11. E. J. VAN BEERS, M. C. L. SCHAAP, R. J. BERCKMANS, R. NIEUWLAND, A. STURK, F. F. VAN DOORMAAL, J. C. M. MEIJERS, & B. J. BIEMOND. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 94, no. 11 (November): 1513-1519 (2009).
12. A. PICCIN, W. G. MURPHY, & O. P. SMITH. Circulating microparticles: pathophysiology and clinical implications. Blood Reviews 21, no. 3 (May): 157-71 (2007).
13. L. C. P. AZEVEDO, M. A. PEDRO, & F. R. M. LAURINDO. Circulating microparticles as therapeutic targets in cardiovascular diseases. Recent Patents on Cardiovascular Drug Discovery 2, no. 1: 41-51 (2007).
14. S. ROBERT, P. PONCELET, R. LACROIX, L. ARNAUD, L. GIRAUDO, A. HAUCHARD, J. SAMPOL, & F. DIGNAT-GEORGE. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? Journal of Thrombosis and Haemostasis 7, no. 1: 190-197 (2009).
15. A. D. MICHELSON. Platelets. Academic Press (2007).
16. F. MOBARREZ, J. ANTOVIC, N. EGBERG, M. HANSSON, G. JRNESKOG, K. HULTENBY, & H. WALLN. A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thrombosis Research In Press, Corrected Proof (n.d.).
17. M. D. SHAH, A. L. BERGERON, J. DONG, & J. A. LPEZ. Flow cytometric measurement of microparticles: pitfalls and protocol modifications. Platelets 19, no. 5: 365-72 (2008).
18. W. R. OVERTON. Modified histogram subtraction technique for analysis of flow cytometry data. Cytometry 9, no. 6: 619-626 (1988).
19. M. ROEDERER, & R. R. HARDY. Frequency difference gating: A multivariate method for identifying subsets that differ between samples. Cytometry 45, no. 1 (9): 56-64 (2001).
20. M. ROEDERER, A. TREISTER, W. MOORE, & L. A. HERZENBERG. Probability binning comparison: A metric for quantitating univariate distribution differences. Cytometry 45, no. 1: 37-46 (2001).
21. M. ROEDERER, W. MOORE, A. TREISTER, R. R. HARDY, & L. A. HERZENBERG. Probability binning comparison: a metric for quantitating multivariate distribution differences. Cytometry 45, no. 1 (9): 47-55 (2001).
22. K. A. BAGGERLY. Probability binning and testing agreement between multivariate immunofluorescence histograms: Extending the chi-squared test. Cytometry 45, no. 2 (10): 141-150 (2001).
23. A. F. OROZCO, & D. E. LEWIS. Flow cytometric analysis of circulating microparticles in plasma. Cytometry Part A 77A, no. 6 (3): 502-514 (2010).
24. H. MAECKER, A. RINFRET, P. D'SOUZA, J. DARDEN, E. ROIG, C. LANDRY, P. HAYES, et al. Standardization of cytokine flow cytometry assays. BMC Immunology 6, no. 1: 13 (2005).
25. B. HUNSBERGER. Improved algorithms for the analysis and classification of HbF-containing Red Blood Cells (n.d.).
26. W. H. B. M. LEVERING, F. W. M. B. PREIJERS, W. N. VAN WIERINGEN, J. KRAAN, W. A. M. VAN BEERS, K. SINTNICOLAAS, D. J. VAN RHENEN, & J. W. GRATAMA. Flow cytometric CD34+ stem cell enumeration: Lessons from nine years' external quality assessment within the Benelux countries. Cytometry Part B: Clinical Cytometry 72B, no. 3 (5): 178-188 (2007).
27. D. LYSK, T. KALINA, J. MARTNEK, Z. PIKALOV, D. VOKURKOV, M. JAREOV, I. MARINOV, A. ONDREJKOV, M. PAEK, & O. STEHLKOV. Interlaboratory variability of CD34+ stem cell enumeration. A pilot study to national external quality assessment within the Czech Republic. International Journal of Laboratory Hematology 32, no. 6 (12): e229-e236 (2010).
28. R. LACROIX, S. ROBERT, P. PONCELET, R. S. KASTHURI, N. S. KEY, F. DIGNAT-GEORGE, & ON BEHALF OF THE ISTH SSC WORKSHOP. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. Journal of Thrombosis and Haemostasis 8, no. 11 (11): 2571-2574 (2010).